当前位置: 首页 > 期刊 > 《中外医学研究》 > 202013
编号:13479972
外周血中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值评估乳腺癌患者预后的价值(3)
http://www.100md.com 2020年5月5日 《中外医学研究》 202013
     [9] Desantis C E,Fedewa S A,Goding S A,et al.Breast cancer statistics,2015:Convergence of incidence rates between black and white women[J].Ca Cancer J Clin,2015,66(1):31-42.

    [10] Ruffell B,Denardo D G,Affara N I,et al.Lymphocytes in cancer development:Polarization towards pro-tumor immunity[J].Cytokine Growth Factor Rev,2010,21(1):3-10.

    [11] Floros T,Tarhini A A.Anticancer cytokines:Biology and clinical effects of interferon-α2,interleukin(IL)-2,IL-15,IL-21,and IL-12[J].Semin Oncol,2015,42(4):539-548.

    [12] Motomura T,Shirabe K,Mano Y,et al.Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment[J].J Hepatol,2013,58(1):58-64.

    [13] Koh C H,Bhoopathy N,Ng K L,et al.Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer[J].Br J Cancer,2015,113(1):150-158.

    [14]張西安,李婷,李斌.自身免疫性肝炎NLR、LMR、PLR及肝功能指标检测结果分析[J].海南医学,2019,30(23):3047-3049.

    [15] Emrah C,Ceren C.The value of neutrophil-to-lymphocyte ratio(NLR) and platelet-to-lymphocyte ratio(PLR) parameters in analysis with fetal malnutrition neonates[J].J Perinat Med,2019,47(7):775-779.

    (收稿日期:2020-02-24) (本文编辑:郎序莹), http://www.100md.com(杨柳 黎彩华)
上一页1 2 3